1.

Record Nr.

UNINA9910698426403321

Titolo

The employment situation [[electronic resource] ] : April 2009 : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Eleventh Congress, first session, May 8, 2009

Pubbl/distr/stampa

Washington : , : U.S. G.P.O., , 2010

Descrizione fisica

1 online resource (iii, 52 pages) : illustrations

Collana

S. hrg. ; ; 111-308

Soggetti

Unemployment - United States

Labor market - United States

Manpower policy - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Title from title screen (viewed on Apr. 9, 2010).



2.

Record Nr.

UNINA9910790418703321

Titolo

Blood and marrow transplantation long-term management : prevention and complications / / edited by Bipin N. Savani

Pubbl/distr/stampa

Chichester, West Sussex, UK : , : John Wiley & Sons, , [2013]

©2013

ISBN

1-118-47334-5

1-118-47330-2

1-118-47337-X

Descrizione fisica

1 online resource (416 p.)

Altri autori (Persone)

SavaniBipin N

Disciplina

616.02/774

Soggetti

Hematopoietic stem cells - Transplantation

Bone marrow - Transplantation

Hematopoietic stem cells - Transplantation - Complications

Bone marrow - Transplantation - Complications

Long-term care of the sick

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

section 1. Late effects concepts -- section 2. Management -- section 3. Supportive care for long-term survivors after HSCT.

Sommario/riassunto

Currently more than 100,000 patients undergo blood and marrow transplantation (BMT) annually worldwide, a number which is steadily increasing. Long-term survival after BMT has improved significantly since its inception over 40 years ago, due to improved supportive care and early recognition of long-term complications. With broadening indications, more options for BMT, and improvement in survival, by 2020 there may be up to a million long-term survivors after BMT globally.   Higher than average rates of second malignancies and cardiopulmonary, infectious, endocrine, and renal diseases, and bon